NCT04828135View on ClinicalTrials.gov

Dual MRI for Cardiopulmonary COVID-19 Long Haulers

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

April 20, 2023

Study Completion Date

April 20, 2023

Conditions
Covid19
Interventions
DRUG

Hyperpolarized 129Xenon gas

Each xenon dose will be limited to a volume less than 25% of subject lung capacity (TLC),

Trial Locations (1)

27705

Duke Asthma, Allergy, and Airway Center, Durham

All Listed Sponsors
lead

Bastiaan Driehuys

OTHER